Corporate Headquarters

                      Abcam plc
                      Discovery Drive
                      Cambridge Biomedical Campus
                      CB2 0AX
                      F: +44 (0)1223 215 215

                      Nominated Advisors and Corporate Broker

                      J.P. Morgan Cazenove
                      25 Bank Street
                      Canary Wharf
                      London E14 5JP

                      Public Relations Advisors

                      FTI Consulting
                      200 Aldersgate
                      Aldersgate Street
                      London EC1A 4HD
                      F: +44 (0)20 3727 1007

                      Joint Corporate Broker

                      Numis Securities Limited
                      The London Stock Exchange Building,
                      10 Paternoster Square, London,
                      EC4M 7LT

                      Note on Unsolicited phone calls

                      We have been made aware of instances where our shareholders have been called regarding their shareholding by persons offering to purchase their shares. This is what is known as a ‘boiler room scam’. Shareholders are advised to be very wary of any unsolicited advice, offers to buy shares at a discount or offers of free company reports. If you receive such a call, you are advised not to get into a conversation, note the name of the person and firm contacting you and then end the call.

                      Worried about shareholder fraud? Click here for advice from the Financial Conduct Authority

                      About Abcam

                      Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

                      Read more +

                      Abcam Products

                      As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

                      Read more +

                      Investor Information

                      Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

                      Read more +

                      Abcam News

                      We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

                      Read more +